Stipple Bio

Cambridge, MA · Founded 2022 · Privately Held (backing)

Operator of a biotechnology company intended to unlock cellular profiling and target discovery. Stipple Bio is based in Cambridge, MA and was founded in 2022. It was valued at $2.2 billion at its early-stage round in Apr 2026, the last priced event on record. It has raised $121 million across 2 recorded rounds; the latest was a $65.1 million later-stage round in Mar 2026.

PMV mark · valuation
$2.2B
Oct 2026
Priced at
its early-stage round
Apr 2026
Total raised
$121.5M
Last round
Later Stage VC
Mar 2026
Cap table — not yet on record

Stipple Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Stipple Bio with a free account
  • ·Watch Stipple Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Stipple Bio

Where does Stipple Bio's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Stipple Bio's 2 recorded funding rounds.